Detalhe da pesquisa
1.
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.
BMC Cancer
; 21(1): 514, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33962592
2.
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response.
J Transl Med
; 15(1): 150, 2017 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-28662677
3.
Harmonization of Serum Thyroid-Stimulating Hormone Measurements Paves the Way for the Adoption of a More Uniform Reference Interval.
Clin Chem
; 63(7): 1248-1260, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522444
4.
Standardization of Free Thyroxine Measurements Allows the Adoption of a More Uniform Reference Interval.
Clin Chem
; 63(10): 1642-1652, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28720678
5.
Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors: The CHEERS Phase 2 Randomized Clinical Trial.
JAMA Oncol
; 9(9): 1205-1213, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410476
6.
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial.
Eur Urol Oncol
; 2023 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37821242
7.
Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases.
EBioMedicine
; 82: 104151, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35843174
8.
Challenges Encountered When Evaluating an Antibody-Detecting Point-of-Care Test for Taeniosis in an Endemic Community in Zambia: A Prospective Diagnostic Accuracy Study.
Diagnostics (Basel)
; 11(11)2021 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34829386
9.
Evaluation of an Antibody Detecting Point of Care Test for Diagnosis of Taenia solium Cysticercosis in a Zambian Rural Community: A Prospective Diagnostic Accuracy Study.
Diagnostics (Basel)
; 11(11)2021 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34829468
10.
Prognostic value of high-risk human papillomavirus DNA and p16INK4a immunohistochemistry in patients with anal cancer: An individual patient data meta-analysis.
Eur J Cancer
; 157: 165-178, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34517306
11.
The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
Eur Urol Focus
; 7(2): 241-244, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386290
12.
Prognostic significance of number versus location of positive mesenteric nodes in stage iii colon cancer.
Eur J Surg Oncol
; 45(10): 1862-1869, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31153766
13.
Randomized Phase 1 Trial of Pembrolizumab with Sequential Versus Concomitant Stereotactic Body Radiotherapy in Metastatic Urothelial Carcinoma.
Eur Urol
; 75(5): 707-711, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665814
14.
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy.
Eur Urol
; 76(6): 732-739, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31331782
15.
Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma.
Int J Radiat Oncol Biol Phys
; 100(4): 906-915, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29485070
16.
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial.
J Clin Oncol
; 36(5): 446-453, 2018 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29240541
17.
Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al.
J Clin Oncol
; 36(22): 2351-2352, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29856691